ID
12796
Description
Rapamycin in Relapsed Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00874562
Link
https://clinicaltrials.gov/show/NCT00874562
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT00874562
Eligibility Acute Lymphoblastic Leukemia NCT00874562
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
acute lymphoblastic leukemia l3 subtype
Data type
boolean
Alias
- UMLS CUI [1]
- C0279582
Description
active infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
pregnant or breastfeeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Description
rapamycin
Data type
boolean
Alias
- UMLS CUI [1]
- C0072980
- UMLS CUI [2]
- C2347852
Description
liver dysfunction
Data type
boolean
Alias
- UMLS CUI [1]
- C0086565
Description
severe concurrent disease
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Description
active psychiatric disease, substance abuse, or mental illness
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00874562
- StudyEvent: Eligibility
C0021083 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C2347852 (UMLS CUI [2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])